Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Pages with the fewest revisions

More actions

Showing below up to 50 results in range #501 to #550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Problem:Ehlers-Danlos Syndrome (1 revision)
  2. Effect:Pupil constriction (1 revision)
  3. Problem:Schizoaffective Disorder (1 revision)
  4. Effect:Compulsive redosing (1 revision)
  5. Problem:Generalized Anxiety Disorder (1 revision)
  6. Effect:Depression reduction (1 revision)
  7. Problem:Dry eye disease (1 revision)
  8. Effect:External hallucination (1 revision)
  9. Problem:Functional Neurological Disorder (1 revision)
  10. Effect:Olfactory hallucination (1 revision)
  11. Problem:Allergic rhinitis (1 revision)
  12. Alexander Shulgin (1 revision)
  13. Effect:Amnesia (1 revision)
  14. Problem:Avoidant/Restrictive Food Intake Disorder (1 revision)
  15. Levothyroxine (2 revisions)
  16. Anastrozole (2 revisions)
  17. Cetirizine (2 revisions)
  18. Phenotype:UGT1A1 normal metabolizer (2 revisions)
  19. Cefuroxime (2 revisions)
  20. Phenotype:CYP3A4 poor metabolizer (2 revisions)
  21. USLegal:Over-the-counter (2 revisions)
  22. Niacin (2 revisions)
  23. Fluconazole (2 revisions)
  24. Hydroxychloroquine (2 revisions)
  25. Tobramycin (2 revisions)
  26. Clindamycin (2 revisions)
  27. Epinephrine (2 revisions)
  28. Percodan (2 revisions)
  29. Dutasteride (2 revisions)
  30. Ceylon cinnamon (2 revisions)
  31. Fenofibrate (2 revisions)
  32. Ketotifen (2 revisions)
  33. Loperamide (2 revisions)
  34. Tamsulosin (2 revisions)
  35. Phenotype:CYP2C9 normal metabolizer (2 revisions)
  36. Nitrofurantoin (2 revisions)
  37. Phenotype:CYP2B6 poor metabolizer (2 revisions)
  38. Fluticasone (2 revisions)
  39. Empagliflozin (2 revisions)
  40. Polyethylene Glycol 3350 With Electrolytes (2 revisions)
  41. Spironolactone (2 revisions)
  42. Progesterone (2 revisions)
  43. Icosapent Ethyl (2 revisions)
  44. Nabumetone (2 revisions)
  45. Avanafil (2 revisions)
  46. Polyethylene Glycol 3350 (2 revisions)
  47. Ezetimibe (2 revisions)
  48. Phenotype:CYP2C19 normal metabolizer (2 revisions)
  49. Ofloxacin (2 revisions)
  50. Phenotype:TPMT poor metabolizer (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)